Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Pohl

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
Wiener Klinische Wochenschrift|July 27, 2016
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) databaseThomas Klikovits, Mir Alireza Hoda, Yawen Dong, et al.
Wiener Klinische Wochenschrift|July 27, 2016
Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)Mir Alireza Hoda, Thomas Klikovits, Madeleine Arns, et al.
Trials|September 20, 2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialMaria Boesing, Kristin Abig, Michael Brändle, et al.
Clinical Medicine Insights. Oncology|September 23, 2020
Results of the Austrian National Lung Cancer AuditOtto C Burghuber, Klaus Kirchbacher, Andrea Mohn-Staudner, et al.
Journal of Asthma and Allergy|March 2, 2026
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize StudyChristian Gessner, Richard E K Russell, Timm Greulich, et al.
Wiener Klinische Wochenschrift|September 29, 2020
[Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria]Michael Studnicka, Bernhard Baumgartner, Josef Bolitschek, et al.
Pneumologie (Stuttgart, Germany)|July 5, 2023
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.]Marek Lommatzsch, Carl-Peter Criée, Carmen C M de Jong, et al.
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
Wiener Klinische Wochenschrift|July 27, 2016
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) databaseThomas Klikovits, Mir Alireza Hoda, Yawen Dong, et al.
Wiener Klinische Wochenschrift|July 27, 2016
Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG)Mir Alireza Hoda, Thomas Klikovits, Madeleine Arns, et al.
Trials|September 20, 2022
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialMaria Boesing, Kristin Abig, Michael Brändle, et al.
Clinical Medicine Insights. Oncology|September 23, 2020
Results of the Austrian National Lung Cancer AuditOtto C Burghuber, Klaus Kirchbacher, Andrea Mohn-Staudner, et al.
Journal of Asthma and Allergy|March 2, 2026
Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize StudyChristian Gessner, Richard E K Russell, Timm Greulich, et al.
Wiener Klinische Wochenschrift|September 29, 2020
[Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria]Michael Studnicka, Bernhard Baumgartner, Josef Bolitschek, et al.
Pneumologie (Stuttgart, Germany)|July 5, 2023
[Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e. V.]Marek Lommatzsch, Carl-Peter Criée, Carmen C M de Jong, et al.
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Pageof 5